131 related articles for article (PubMed ID: 24792401)
21. Evaluation of a single-visit approach to cervical cancer screening and treatment in Guyana: feasibility, effectiveness and lessons learned.
Martin CE; Tergas AI; Wysong M; Reinsel M; Estep D; Varallo J
J Obstet Gynaecol Res; 2014 Jun; 40(6):1707-16. PubMed ID: 24888938
[TBL] [Abstract][Full Text] [Related]
22. Cervical cancer screening behaviours and challenges: a sub-Saharan Africa perspective.
Anaman-Torgbor J; Angmorterh SK; Dordunoo D; Ofori EK
Pan Afr Med J; 2020; 36():97. PubMed ID: 32774656
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of cervical-cancer screening in five developing countries.
Goldie SJ; Gaffikin L; Goldhaber-Fiebert JD; Gordillo-Tobar A; Levin C; Mahé C; Wright TC;
N Engl J Med; 2005 Nov; 353(20):2158-68. PubMed ID: 16291985
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country setting.
Mansergh G; Haddix AC; Steketee RW; Nieburg PI; Hu DJ; Simonds RJ; Rogers M
JAMA; 1996 Jul; 276(2):139-45. PubMed ID: 8656506
[TBL] [Abstract][Full Text] [Related]
25. Cervical cancer screening: Safety, acceptability, and feasibility of a single-visit approach in Bulawayo, Zimbabwe.
Fallala MS; Mash R
Afr J Prim Health Care Fam Med; 2015 May; 7(1):. PubMed ID: 26245601
[TBL] [Abstract][Full Text] [Related]
26. An extended cost-effectiveness analysis of publicly financed HPV vaccination to prevent cervical cancer in China.
Levin CE; Sharma M; Olson Z; Verguet S; Shi JF; Wang SM; Qiao YL; Jamison DT; Kim JJ
Vaccine; 2015 Jun; 33(24):2830-41. PubMed ID: 25770785
[TBL] [Abstract][Full Text] [Related]
27. Overview of cervical cancer screening practices in the extended Middle East and North Africa countries.
Sancho-Garnier H; Khazraji YC; Cherif MH; Mahnane A; Hsairi M; El Shalakamy A; Osgul N; Tuncer M; Jumaan AO; Seoud M
Vaccine; 2013 Dec; 31 Suppl 6():G51-7. PubMed ID: 24331820
[TBL] [Abstract][Full Text] [Related]
28. Cervical cancer: the sub-Saharan African perspective.
Anorlu RI
Reprod Health Matters; 2008 Nov; 16(32):41-9. PubMed ID: 19027621
[TBL] [Abstract][Full Text] [Related]
29. Cervical cancer screening uptake in Sub-Saharan Africa: a systematic review and meta-analysis.
Yimer NB; Mohammed MA; Solomon K; Tadese M; Grutzmacher S; Meikena HK; Alemnew B; Sharew NT; Habtewold TD
Public Health; 2021 Jun; 195():105-111. PubMed ID: 34082174
[TBL] [Abstract][Full Text] [Related]
30. Effective screening programmes for cervical cancer in low- and middle-income developing countries.
Sankaranarayanan R; Budukh AM; Rajkumar R
Bull World Health Organ; 2001; 79(10):954-62. PubMed ID: 11693978
[TBL] [Abstract][Full Text] [Related]
31. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of rapid point-of-care prenatal syphilis screening in sub-Saharan Africa.
Rydzak CE; Goldie SJ
Sex Transm Dis; 2008 Sep; 35(9):775-84. PubMed ID: 18607319
[TBL] [Abstract][Full Text] [Related]
33. Model-based estimates of risks of disease transmission and economic costs of seven injection devices in sub-Saharan Africa.
Ekwueme DU; Weniger BG; Chen RT
Bull World Health Organ; 2002; 80(11):859-70. PubMed ID: 12481207
[TBL] [Abstract][Full Text] [Related]
34. Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK.
Brown RE; Breugelmans JG; Theodoratou D; Bénard S
Curr Med Res Opin; 2006 Apr; 22(4):663-70. PubMed ID: 16684427
[TBL] [Abstract][Full Text] [Related]
35. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial.
Sankaranarayanan R; Esmy PO; Rajkumar R; Muwonge R; Swaminathan R; Shanthakumari S; Fayette JM; Cherian J
Lancet; 2007 Aug; 370(9585):398-406. PubMed ID: 17679017
[TBL] [Abstract][Full Text] [Related]
36. Health systems challenges in cervical cancer prevention program in Malawi.
Maseko FC; Chirwa ML; Muula AS
Glob Health Action; 2015; 8():26282. PubMed ID: 25623612
[TBL] [Abstract][Full Text] [Related]
37. HPV self-sampling as primary screening test in sub-Saharan Africa: implication for a triaging strategy.
Untiet S; Vassilakos P; McCarey C; Tebeu PM; Kengne-Fosso G; Menoud PA; Boulvain M; Navarria I; Petignat P
Int J Cancer; 2014 Oct; 135(8):1911-7. PubMed ID: 24615324
[TBL] [Abstract][Full Text] [Related]
38. Meeting the cervical cancer screening needs of underserved women: the National Breast and Cervical Cancer Early Detection Program, 2004-2006.
Tangka FK; O'Hara B; Gardner JG; Turner J; Royalty J; Shaw K; Sabatino S; Hall IJ; Coates RJ
Cancer Causes Control; 2010 Jul; 21(7):1081-90. PubMed ID: 20361353
[TBL] [Abstract][Full Text] [Related]
39. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.
Goldie SJ; O'Shea M; Campos NG; Diaz M; Sweet S; Kim SY
Vaccine; 2008 Jul; 26(32):4080-93. PubMed ID: 18550229
[TBL] [Abstract][Full Text] [Related]
40. Prevalence, Predictors, and Same Day Treatment of Positive VIA Enhanced by Digital Cervicography and Histopathology Results in a Cervical Cancer Prevention Program in Cameroon.
DeGregorio GA; Bradford LS; Manga S; Tih PM; Wamai R; Ogembo R; Sando Z; Liu Y; Schwaiger C; Rao SR; Kalmakis K; Kennedy Sheldon L; Nulah K; Welty E; Welty T; Ogembo JG
PLoS One; 2016; 11(6):e0157319. PubMed ID: 27280882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
